product summary
Loading...
company name :
DIMA Biotechnology
product type :
protein
product name :
Human BTLA Protein, mFc-His Tag
catalog :
PME100048
quantity :
10 μg, 100 μg
price :
60 USD, 338 USD
more info or order :
image
image 1 :
DIMA Biotechnology PME100048 image 1
Figure 1. Human BTLA Protein, mFc-His Tag on SDS-PAGE under reducing condition.
product information
Catalog Number :
PME100048
Product Name :
Human BTLA Protein, mFc-His Tag
Product Type :
protein
Size :
10 μg, 100 μg
List Price :
60 USD, 338 USD
Product Description :
Recombinant human BTLA protein with C-terminal mouse Fc and 6×His tag
Background :
This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis.
Purity :
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining.
Buffer :
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 23 % trehalose is added as protectants before lyophilization.
Uses :
Research use only
Application Summary :
Immunogen,WB,Elisa
Storage :
Store at -80°C for 12 months (Avoid repeated freezing and thawing)
more info or order :
company information
DIMA Biotechnology
Wuhan institute of Biotechnology B7
Biolake No.666 Gaoxin Road
Wuhan, Hubei
info@dimabio.com
https://www.dimabio.com
0118615307149771
headquarters: China
DIMA BIOTECH LTD (DIMABIO) focuses exclusively on the pre-clinical research market of Immune Oncology. Currently, we offer functional proteins and recombinant monoclonal antibodies. Our proprietary DimAb™ technology platform can directly clone IgG gene from immunized animal, which is a technology breakthrough in monoclonal antibody development.

All DIMABIOs protein products were manufactured by using mammalian cell expression system. To analyze the function of DIMABIOs proteins, we evaluated them by paired binding test between native ligand-receptor and or the binding capacity to the therapeutic antibodies. For DimAb™ recombinant monoclonal antibodies, we focus mainly on identifying clones with flow and blocking activity.